| Norovirus E Robilotti, S Deresinski, BA Pinsky Clinical microbiology reviews 28 (1), 134-164, 2015 | 724 | 2015 |
| Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey S Deresinski Clinical infectious diseases 40 (4), 562-573, 2005 | 667 | 2005 |
| Posaconazole: a broad-spectrum triazole antifungal agent V Nagappan, S Deresinski Clinical Infectious Diseases 45 (12), 1610-1617, 2007 | 274 | 2007 |
| Counterpoint: Vancomycin and Staphylococcus aureus—An Antibiotic Enters Obsolescence S Deresinski Clinical Infectious Diseases 44 (12), 1543-1548, 2007 | 232 | 2007 |
| Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections S Deresinski Clinical Infectious Diseases 49 (7), 1072-1079, 2009 | 206 | 2009 |
| Infectious complications of multiple sclerosis therapies: implications for screening, prophylaxis, and management DJ Epstein, J Dunn, S Deresinski Open forum infectious diseases 5 (8), ofy174, 2018 | 157 | 2018 |
| Comprehensive guidance for antibiotic dosing in obese adults L Meng, E Mui, MK Holubar, SC Deresinski Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (11 …, 2017 | 156 | 2017 |
| Bacteriophage therapy: exploiting smaller fleas S Deresinski Clinical infectious diseases 48 (8), 1096-1101, 2009 | 149 | 2009 |
| Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data S Deresinski Clinical infectious diseases 45 (Supplement_3), S177-S183, 2007 | 146 | 2007 |
| Mycotic Infections Acquired outside Areas of Known Endemicity, United States-Volume 21, Number 11—November 2015-Emerging Infectious Diseases journal-CDC K Benedict, GR Thompson, S Deresinski, T Chiller Emerging infectious diseases 21 (11), 1935-1941, 2015 | 91 | 2015 |
| Conversion from vancomycin trough concentration–guided dosing to area under the curve–guided dosing using two sample measurements in adults: implementation at an academic … L Meng, T Wong, S Huang, E Mui, V Nguyen, G Espinosa, J Desai, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (4 …, 2019 | 90 | 2019 |
| Plasma microbial cell-free DNA next-generation sequencing in the diagnosis and management of febrile neutropenia E Benamu, K Gajurel, JN Anderson, T Lieb, CA Gomez, H Seng, R Aquino, ... Clinical Infectious Diseases 74 (9), 1659-1668, 2022 | 87 | 2022 |
| When sepsis persists: a review of MRSA bacteraemia salvage therapy R Kullar, G Sakoulas, S Deresinski, SJ van Hal Journal of Antimicrobial Chemotherapy 71 (3), 576-586, 2016 | 84 | 2016 |
| Real-time electronic tracking of diarrheal episodes and laxative therapy enables verification of Clostridium difficile clinical testing criteria and reduction of Clostridium … CY Truong, S Gombar, R Wilson, G Sundararajan, N Tekic, M Holubar, ... Journal of clinical microbiology 55 (5), 1276-1284, 2017 | 78 | 2017 |
| Norfloxacin for prevention of bacterial infections in granulocytopenic patients DJ Winston, WG Ho, RE Champlin, J Karp, J Bartlett, RS Finley, JH Joshi, ... The American journal of medicine 82 (6), 40-46, 1987 | 72 | 1987 |
| Increasing evidence of the nephrotoxicity of piperacillin/tazobactam and vancomycin combination therapy—what is the clinician to do? RR Watkins, S Deresinski Clinical Infectious Diseases 65 (12), 2137-2143, 2017 | 67 | 2017 |
| Vancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus S Deresinski The Journal of infectious diseases 199 (5), 605-609, 2009 | 66 | 2009 |
| Rare and emerging viral infections in transplant recipients JJ Waggoner, EA Soda, S Deresinski Clinical infectious diseases 57 (8), 1182-1188, 2013 | 63 | 2013 |
| Oral fluoroquinolone or trimethoprim-sulfamethoxazole vs ß-lactams as step-down therapy for Enterobacteriaceae bacteremia: systematic review and meta-analysis C Punjabi, V Tien, L Meng, S Deresinski, M Holubar Open Forum Infectious Diseases 6 (10), ofz364, 2019 | 57 | 2019 |
| Bacteremia due to methicillin-resistant Staphylococcus aureus: new therapeutic approaches M Holubar, L Meng, S Deresinski Infectious Disease Clinics 30 (2), 491-507, 2016 | 56 | 2016 |
